Merck and Samsung Bioepis enter collaboration agreement to develop and commercialize insulin glargine candidate for diabetes
Merck and Samsung Bioepis Co., Ltd., announced that they have…
10 February 2014 | By Merck
Merck and Samsung Bioepis Co., Ltd., announced that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293...